Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells

被引:116
作者
Garofalo, C
Sisci, D
Surmacz, E
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Univ Calabria, Fac Pharm, Cosenza, Italy
关键词
D O I
10.1158/1078-0432.CCR-04-0203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Obesity is a risk factor for breast cancer development in postmenopausal women and correlates with shorter disease-free and overall survival in breast cancer patients, regardless of menopausal status. Adipose tissue is a major source of leptin, a cytokine regulating energy balance and controlling different processes in peripheral tissues, including breast cancer cell growth. Here, we investigated whether leptin can counteract antitumorigenic activities of the antiestrogen ICI 182,780 in breast cancer cells. Experimental Design: Mitogenic response to leptin and the effects of leptin on ICI 182,780-dependent growth inhibition were studied in MCF-7 estrogen receptor alpha-positive breast cancer cells. The expression of leptin receptor and the activation of signaling pathways were studied by Western immunoblotting. The interference of leptin with ICI 182,780-induced estrogen receptor alpha degradation was probed by Western immunoblotting, fluorescence microscopy, and pulse-chase experiments. Leptin effects on estrogen receptor alpha-dependent transcription in the presence and absence of ICI 182,780 were studied by luciferase reporter assays and chromatin immunoprecipitation. Results: MCF-7 cells were found to express the leptin receptor and respond to leptin with cell growth and activation the signal transducers and activators of transcription 3, extracellular signal-regulated kinase-1/2, and Akt/GSK3/pRb pathways. The exposure of cells to 10 nmol/L ICI 182,780 blocked cell proliferation, induced rapid estrogen receptor alpha degradation, inhibited nuclear estrogen receptor alpha expression, and reduced estrogen receptor alpha-dependent transcription from estrogen response element-containing promoters. All of these effects of ICI 182,780 were significantly attenuated by simultaneous treatment of cells with 100 ng/mL leptin. Conclusions: Leptin interferes with the effects of ICI 182,780 on estrogen receptor alpha in breast cancer cells. Thus, high leptin levels in obese breast cancer patients might contribute to the development of antiestrogen resistance.
引用
收藏
页码:6466 / 6475
页数:10
相关论文
共 60 条
[11]   The underlying basis for obesity: Relationship to cancer [J].
Bray, GA .
JOURNAL OF NUTRITION, 2002, 132 (11) :3451S-3455S
[12]  
Bundred Nigel, 2002, Expert Rev Anticancer Ther, V2, P151, DOI 10.1586/14737140.2.2.151
[13]   Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor α in MCF-7 cells [J].
Catalano, S ;
Mauro, L ;
Marsico, S ;
Giordano, C ;
Rizza, P ;
Rago, V ;
Montanaro, D ;
Maggiolini, M ;
Panno, ML ;
Andó, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) :19908-19915
[14]   Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line [J].
Catalano, S ;
Marsico, S ;
Giordano, C ;
Mauro, L ;
Rizza, P ;
Panno, ML ;
Andò, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28668-28676
[15]   Weight loss in breast cancer patient management [J].
Chlebowski, RT ;
Aiello, E ;
McTiernan, A .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) :1128-1143
[16]   Genetically obese MMTV-TGF-α/LepobLepob female mice do not develop mammary tumors [J].
Cleary, MP ;
Phillips, FC ;
Getzin, SC ;
Jacobson, TL ;
Jacobson, MK ;
Christensen, TA ;
Juneja, SC ;
Grande, JP ;
Maihle, NJ .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 77 (03) :205-215
[17]  
Cleary MP, 1997, P SOC EXP BIOL MED, V216, P28, DOI 10.3181/00379727-216-44153B
[18]   ANTIESTROGEN ICI-164,384 REDUCES CELLULAR ESTROGEN-RECEPTOR CONTENT BY INCREASING ITS TURNOVER [J].
DAUVOIS, S ;
DANIELIAN, PS ;
WHITE, R ;
PARKER, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4037-4041
[19]   Leptin mediates a proliferative response in human MCF7 breast cancer cells [J].
Dieudonne, MN ;
Machinal-Quelin, F ;
Serazin-Leroy, V ;
Leneveu, MC ;
Pecquery, R ;
Giudicelli, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (01) :622-628
[20]   The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-α and essential for the anti proliferative activity of ICI 182,780 in ERα-positive breast cancer cells [J].
Fan, MY ;
Bigsby, RM ;
Nephew, KP .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (03) :356-365